Emerging Targets for the Treatment of Dyslipidemia
Keywords: Antisense oligonucleotides; HDL-modifying agents; LDL- cholesterol levels; atherosclerotic cardiovascular disease; cholesterol-lowering agents; dyslipidemia; microsomal triglyceride transfer protein inhibitors; peroxisome proliferator-activated receptor agonists; squalene synthase inhibitors; thyroid hormone receptor agonists
Document Type: Research Article
Publication date: 2011-02-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.